Newer agents for hormonal contraception in the male

被引：19

作者：

Amory, JK ^{[1
]}

Bremner, WJ

机构：

[1] Puget Sound Hlth Care Syst, Populat Ctr Res Reprod, Dept Vet Affairs, Seattle, WA 98195 USA

[2] Univ Washington, Dept Med, Seattle, WA 98195 USA

来源：

TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2000年 / 11卷 / 02期

关键词：

D O I：

10.1016/S1043-2760(99)00224-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Efforts to create a hormonal contraceptive for men use testosterone to suppress the production of pituitary gonadotropins and hence, spermatogenesis. However, conventional testosterone must be administered by frequent injection, and, when given alone, is not 100% effective. Therefore, newer androgens and agents that synergistically suppress gonadotropin production are being studied to create an effective and commercially viable contraceptive.

引用

页码：61 / 66

页数：6

共 37 条

[1] The use of testosterone as a male contraceptive [J].

Amory, JK ;

Bremner, WJ .

BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1998, 12 (03) :471-484

[2]

Anawalt BD, 1999, J ANDROL, V20, P407

[3] Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study .3. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterones [J].

Anderson, RA ;

Wallace, AM ;

Wu, FCW .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (03) :902-908

[4]

Aribarg A, 1996, FERTIL STERIL, V65, P821

[5] COMPARISON OF A GONADOTROPIN-RELEASING-HORMONE ANTAGONIST PLUS TESTOSTERONE (T) VERSUS-T ALONE AS POTENTIAL MALE CONTRACEPTIVE REGIMENS [J].

BAGATELL, CJ ;

MATSUMOTO, AM ;

CHRISTENSEN, RB ;

RIVIER, JE ;

BREMNER, WJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) :427-432

[6] Drug therapy - Androgens in men - Uses and abuses [J].

Bagatell, CJ ;

Bremner, WJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :707-714

[7] METABOLIC AND BEHAVIORAL-EFFECTS OF HIGH-DOSE, EXOGENOUS TESTOSTERONE IN HEALTHY-MEN [J].

BAGATELL, CJ ;

HEIMAN, JR ;

MATSUMOTO, AM ;

RIVIER, JE ;

BREMNER, WJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (02) :561-567

[8] PREGNANCIES ASSOCIATED WITH SPERM CONCENTRATIONS BELOW 10 MILLION-ML IN CLINICAL STUDIES OF A POTENTIAL MALE CONTRACEPTIVE METHOD, MONTHLY DEPOT MEDROXYPROGESTERONE ACETATE AND TESTOSTERONE ESTERS [J].

BARFIELD, A ;

MELO, J ;

COUTINHO, E ;

ALVAREZSANCHEZ, F ;

FAUNDES, A ;

BRACHE, V ;

LEON, P ;

FRICK, J ;

BARTSCH, G ;

WEISKE, WH ;

BRENNER, P ;

MISHELL, D ;

BERNSTEIN, G ;

ORTIZ, A .

CONTRACEPTION, 1979, 20 (02) :121-127

[9] Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach [J].

Bebb, RA ;

Anawalt, BD ;

Christensen, RB ;

Paulsen, CA ;

Bremner, WJ ;

Matsumoto, AM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02) :757-762

[10] Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism:: phase I studies [J].

Behre, HM ;

Abshagen, K ;

Oettel, M ;

Hübler, D ;

Nieschlag, E .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (05) :414-419

← 1 2 3 4 →